Immunization against genital human papillomaviruses

Pediatric Infectious Disease Journal

Volumn 24, Issue 11, 2005, Pages 1005-1006

  Bonnez, William ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Cancer; Genital infections; Immunization; Papillomavirus; Sexually transmitted diseases

Indexed keywords

RECOMBINANT VACCINE; VIRUS VACCINE;

CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DNA VIRUS; FOLLOW UP; GENETIC ENGINEERING; GENITAL TRACT INFECTION; HEALTH CARE COST; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SEXUAL BEHAVIOR; SHORT SURVEY; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION; VERRUCA VULGARIS; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS PARTICLE; WART VIRUS;

EID: 28044434379     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000186296.52985.ba     Document Type: Review

References (15)

1. Bosch FX, et al. Chap. 1: HPV and cervical cancer . . .. J Natl Cancer Inst Monogr. 2003;31:3-13.
2. Moscicki AB. HPV, Pap smears, and the college female. Pediatr Clin North Am. 2005;52:163-177.
3. Monsonego J, et al. Cervical cancer control . . .. Int J Cancer. 2004;108:329-333.
4. Parkin DM, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
5. Goldie SJ, et al. Projected clinical benefits and cost-effectiveness of . . . HPV 16/18 vaccine. J Natl Cancer Inst. 2004;96:604-615.
6. Bonnez W, et al. Antibody-mediated neutralization of HPV-11 . . .. J Infect Dis. 1992;165:376-380.
7. Kirnbauer R, et al. Papillomavirus L1 major capsid protein self-assembles . . .. Proc Natl Acad Sci USA. 1992;89:12180-12184.
8. Rose RC, et al. Expression of HPV type 11 L1 protein in insect cells . . . assembly of VLPs. J Virol. 1993;67:1936-1944.
9. Harro CD, et al. Safety and immunogenicity trial in adults . . . of an HPV type 16 L1 VLP vaccine. J Natl Cancer Inst. 2001;93:284-292.
10. Evans TG, et al. A phase 1 study of a recombinant VLP vaccine against HPV type 11 in healthy adults . . .. J Infect Dis. 2001;183:1485-1493.
11. Koutsky LA, et al. A controlled trial of an HPV type 16 vaccine. N Engl J Med. 2002;347:1645-1651.
12. Harper DM, et al. Efficacy of a bivalent L1 VLP vaccine in prevention of . . . HPV types 16 and 18 in young women . . .. Lancet. 2004;364:1757-1765.
13. Villa LL, et al. Prophylactic quadrivalent HPV (types 6, 11, 16, and 18) L1 VLP vaccine in young women . . .. Lancet Oncol. 2005;6:271-278.
14. Pagliusi SR, et al. Efficacy and other milestones for HPV vaccine introduction. Vaccine. 2004;23:569-578.
15. Anhang R, et al. HPV communication: review of existing research and recommendations for patient education. CA Cancer J Clin. 2004;54:248-259.